Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Fairwinds Enhances Kubernetes Workload Cost Allocation Feature to Pinpoint Application Cloud Spend
    Fairwinds Enhances Kubernetes Workload Cost Allocation Feature to Pinpoint Application Cloud Spend Business
  • It’s Not Too Late to Register for the 2023 FAA Drone Symposium and Advanced Air Mobility Summit
    It’s Not Too Late to Register for the 2023 FAA Drone Symposium and Advanced Air Mobility Summit Aviation
  • War Day 182: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych  & #Feygin
    War Day 182: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • War Day 283: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 283: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Global Industrial Refrigeration Equipment Market Projected to Discern Stable Expansion during 2017-2026
    Global Industrial Refrigeration Equipment Market Projected to Discern Stable Expansion during 2017-2026 World News
  • Senators Introduce Bipartisan Anti-Horse Slaughter Legislation as a Companion to House bill, Seek Farm bill Amendment
    Senators Introduce Bipartisan Anti-Horse Slaughter Legislation as a Companion to House bill, Seek Farm bill Amendment World News
  • War in Ukraine, Analytics. Day 761 (part2): Mass Psychosis & Degradation of Russia
    War in Ukraine, Analytics. Day 761 (part2): Mass Psychosis & Degradation of Russia World News
  • S3 AeroDefense Announces New Distribution Agreement with Rogerson Kratos
    S3 AeroDefense Announces New Distribution Agreement with Rogerson Kratos Aviation
TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

Posted on March 15, 2023 By NewsEditor
TTC Oncology LLC Signs a Collaboration Agreement With Lantern PharmaTTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

EDINA, Minn., March 15, 2023 (Newswire.com) - TTC Oncology ("TTC" or the "Company") announced the signing of a Collaboration Agreement (the "Agreement") with Lantern Pharma Inc. ("LTRN") to expand the clinical development of the TTC drug candidate TTC-352. The Phase-2 ready candidate, TTC-352, is an orally available small molecule being developed as a treatment for patients with metastatic estrogen receptor-positive ("ER+") breast cancer who have failed two or more prior therapies. TTC-352 is a first-in-class selective human ER partial agonist (ShERPA) that in metastatic disease causes ER to induce breast cancer cell death.

The collaboration will be powered by Lantern's artificial intelligence (AI) platform, RADR®, and its 25+ billion oncology-focused data points, 200+ advanced ML algorithms, as well as its four multi-faceted AI drug discovery and development modules. The initial aims of the collaboration will be to 1) identify biomarker or gene signatures to power potential patient selection for an upcoming TTC-352 Phase 2 clinical trial, 2) further characterize TTC-352's mechanism of action, and 3) discover additional treatment indications for TTC-352.

Breast cancer afflicts approximately 2.1 million women in the U.S. yearly with the majority of these cases being ER+, in which ER promotes tumor growth. Patients with ER+ breast cancer are initially treated with endocrine therapy, which blocks the tumorigenic actions of ER. Unfortunately, almost half of all patients who undergo endocrine therapy develop endocrine-resistant metastatic disease and will need chemotherapy as a last resort. TTC-352 provides an alternative approach without the toxicity associated with chemotherapy. 

Under the terms of the collaboration, Lantern Pharma is receiving an exclusive right to license TTC-352, including any collaboration intellectual property (IP), during an exclusive option period. Additionally, Lantern and TTC will each participate in upfront, milestone, and royalty payments in the event a third party licenses IP resulting from the collaboration. No further financial details were disclosed.

About Lantern Pharma

Lantern Pharma ("LTRN") is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR® AI and machine learning platform to discover biomarker signatures that identify patients most likely to respond to its pipeline of genomically-targeted therapeutics. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, Lantern's approach represents the potential to deliver best-in-class outcomes. For more information, please visit the company's website at www.lanternpharma.com.

About TTC Oncology LLC

TTC Oncology is an emerging biotechnology company founded in 2015. TTC Oncology's mission is to develop and bring to market a novel, small-molecule therapy, TTC-352, to address the unmet needs of breast cancer patients. TTC has a license from the University of Illinois at Chicago covering the therapy. https://ttconcology.com/ TTC is currently raising funds to complete Phase II studies. 

Contact Information:
Joe Cunningham
CFO
[email protected]
6129911778


Original Source: TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

The post TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma first appeared on Social Gov.

Business

Post navigation

Previous Post: Diverge Health Launched to Build Upon a Decade of Experience Serving Underserved Patients in New York
Next Post: Augmenta acquired by CNH Industrial

Related Posts

  • SESHBUDDIES Launches a New Era of Cannabis Social Media Where Enthusiasts, Insiders, and Brands Come Together
    SESHBUDDIES Launches a New Era of Cannabis Social Media Where Enthusiasts, Insiders, and Brands Come Together Business
  • ICA Offers Live Classes in Arkansas for Home Inspector Continuing Education
    ICA Offers Live Classes in Arkansas for Home Inspector Continuing Education Business
  • New Report Shows Legacy Methods Becoming Obsolete
    New Report Shows Legacy Methods Becoming Obsolete Business
  • KaJ Labs Launches  Billion Web3, AI Grant Program for Lithosphere (LITHO) & Jot Art (JOT) Developers
    KaJ Labs Launches $1 Billion Web3, AI Grant Program for Lithosphere (LITHO) & Jot Art (JOT) Developers Business
  • Mini Mall Storage Offers Drive Up Storage Units And Parking Spots For RVs, Boats, And Other Vehicles in Greencastle, IN
    Mini Mall Storage Offers Drive Up Storage Units And Parking Spots For RVs, Boats, And Other Vehicles in Greencastle, IN Business
  • 2022 Balance Sheet: Gebrüder Weiss Continues to Grow
    2022 Balance Sheet: Gebrüder Weiss Continues to Grow Business
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Apr    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Bombardier annonce l’élection de son conseil d’administrationMay 10, 2025
  • Gorfion Green Energy und EnoPark starten strategische PartnerschaftMay 10, 2025
  • New Satellite Website Enhances Reach and Impact of Candid Wedding PhotographyMay 9, 2025
  • GALT Aerospace Achieves CMMC Level 2 Certification, Strengthening Commitment to CybersecurityMay 9, 2025
  • Cambridge Online Tutors is Leading the Way in Effective Online Tutoring for Student SuccessMay 9, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Secretary Antony J. Blinken Opening Remarks Before the House Committee on Foreign Affairs On the FY24 Department of State Budget Request
    Secretary Antony J. Blinken Opening Remarks Before the House Committee on Foreign Affairs On the FY24 Department of State Budget Request World News
  • War Day 303: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 303: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • The Secure Messaging In Healthcare Market to Grow Beyond Linear Progression at a CAGR of 20%
    The Secure Messaging In Healthcare Market to Grow Beyond Linear Progression at a CAGR of 20% World News
  • War Day 617: Zaluzhny’s Interview: Finding an Exit From a Stalemate
    War Day 617: Zaluzhny’s Interview: Finding an Exit From a Stalemate World News
  • OPIC Technologies, Inc. Uses Spatial Livestreaming to Help Families and Friends Stay Connected
    OPIC Technologies, Inc. Uses Spatial Livestreaming to Help Families and Friends Stay Connected World News
  • ‘Listen To This Beat And Relax’ With Quan Aqua Faust’s New Song, “Got Me Like”
    ‘Listen To This Beat And Relax’ With Quan Aqua Faust’s New Song, “Got Me Like” World News
  • Time Capsule by Koichi Namimoto Wins Bronze in A’ Packaging Design Awards
    Time Capsule by Koichi Namimoto Wins Bronze in A’ Packaging Design Awards World News
  • Juan Carlos Samaniego Achieves Amazon Best-Seller Status with “Never Give Up,” Co-Authored with Dick Vitale
    Juan Carlos Samaniego Achieves Amazon Best-Seller Status with “Never Give Up,” Co-Authored with Dick Vitale Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .